GenePlanet

GenePlanet is a Slovenian biotech company that provides preventive genetic testing solutions for both clinical and lifestyle purposes. Founded in 2008 by Marko Bitenc and Špela Stres, the company is headquartered in Ljubljana, Slovenia. CEO Marko Bitenc has a background in cellular and molecular biotechnology and previously co-founded Universal Diagnostics, a company focused on early cancer detection. Špela Stres has extensive experience in technology transfer, innovation systems, and has held positions at the Jožef Stefan Institute and the European Innovation Council Board.

The company operates on a B2B and B2C model, collaborating with over 1,000 medical centers, doctors, and insurance companies, as well as offering direct-to-consumer tests. Its primary market is Central and Eastern Europe, but it has a presence in over 35 countries across Europe, Asia, and Latin America. GenePlanet generates revenue through the sale of its genetic testing kits and has an estimated revenue range of $10M to $25M. The company has raised a total of $34 million in funding over two rounds, with a significant Series B round of €20 million in July 2023 led by BlackPeak Capital. This funding is aimed at global expansion, new product development, and investment in big data infrastructure and AI capabilities for genome interpretation.

GenePlanet's product portfolio includes clinical genetic tests and lifestyle DNA tests. A key clinical offering is the Non-Invasive Prenatal Test (NIPT), which screens for chromosomal abnormalities in a fetus during early pregnancy. The company also provides genetic tests for hereditary cancer risk assessment and venous thromboembolism risk. Its lifestyle tests offer individuals insights into their genetic predispositions related to diet, exercise, stress, and other lifestyle factors, providing personalized recommendations. Customers receive a saliva collection kit and send the sample to GenePlanet's lab for analysis. The company is developing a digital health engagement platform called Health Intelligence, which combines genetic data with blood tests and lifestyle assessments to provide a holistic health score and personalized guidance.

Keywords: genetic testing, DNA analysis, preventive healthcare, NIPT, cancer screening, lifestyle genetics, personalized medicine, biotechnology, molecular diagnostics, non-invasive prenatal testing, whole genome sequencing, health and wellness, diet genetics, fitness genetics, hereditary risk assessment, direct-to-consumer genetics, clinical diagnostics, Health Intelligence platform, Marko Bitenc, Špela Stres